BIOEPCIN
Live / Applied — Third extension granted (statement of use) (as of 11 Feb 2026)
What this means for you
Not registered yet, but its 04 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98483711
- Mark type
- Stylized text
- Filed
- 04 Apr 2024
- Published for opposition
- 18 Jun 2024
- Attorney of record
- Bentley J. Olive
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions and preparations, namely, pharmaceutical compositions and preparations of the immunomodulator glatiramer acetate for treatment of multiple sclerosis
Owner
- Biocon Limited, Karnataka, IN
- Biocon Limited, Karnataka, IN
Prosecution history
- 11 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2026 — SOU EXTENSION 3 GRANTED
- 11 Feb 2026 — SOU EXTENSION 3 FILED
- 11 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2025 — SOU EXTENSION 2 GRANTED
- 28 Jul 2025 — SOU EXTENSION 2 FILED
- 28 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2025 — SOU EXTENSION 1 GRANTED
- 21 Jan 2025 — SOU EXTENSION 1 FILED
- 21 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED